Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
31.37
-2.43 (-7.19%)
At close: Oct 30, 2026, 4:00 PM EST
29.49
-1.88 (-5.99%)
Pre-market: Nov 2, 2026, 4:19 AM EST
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.6 billion as of October 30, 2026. Its market cap has increased by 82.84% in one year.
Market Cap
1.60B
Enterprise Value
1.59B
1-Year Change
82.84%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on December 11, 2020, Nanobiotix's market cap has increased from $549.07M to $1.60B, an increase of 190.56%. That is a compound annual growth rate of 19.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.60B | 44.03% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nuvation Bio | 1.67B |
| Replimune Group | 1.67B |
| Kailera Therapeutics | 1.67B |
| Novavax | 1.66B |
| Mineralys Therapeutics | 1.61B |
| UroGen Pharma | 1.60B |
| Ultragenyx Pharmaceutical | 1.58B |
| Immunocore Holdings | 1.57B |